阿卡鲁替尼与来那度胺和利妥昔单抗联合治疗滤泡性淋巴瘤取得令人鼓舞的结果

{"title":"阿卡鲁替尼与来那度胺和利妥昔单抗联合治疗滤泡性淋巴瘤取得令人鼓舞的结果","authors":"Robert van den Heuvel","doi":"10.55788/5dcb20eb","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":517344,"journal":{"name":"Medicom Conference Report ASH 2023","volume":"23 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Encouraging results for the addition of acalabrutinib to lenalidomide and rituximab in follicular lymphoma\",\"authors\":\"Robert van den Heuvel\",\"doi\":\"10.55788/5dcb20eb\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":517344,\"journal\":{\"name\":\"Medicom Conference Report ASH 2023\",\"volume\":\"23 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicom Conference Report ASH 2023\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.55788/5dcb20eb\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicom Conference Report ASH 2023","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.55788/5dcb20eb","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}